The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
Stine, Jessica E, Guo, Hui, Sheng, Xiugui, Han, Xiaoyun, Schointuch, Monica N, Gilliam, Timothy P, Gehrig, Paola A, Zhou, Chunxiao, Bae-Jump, Victoria L
Published in Oncotarget (05.01.2016)
Published in Oncotarget (05.01.2016)
Get full text
Journal Article
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer
Schointuch, Monica N, Gilliam, Timothy P, Stine, Jessica E, Han, Xiaoyun, Zhou, Chunxiao, Gehrig, Paola A, Kim, Kenneth, Bae-Jump, Victoria L
Published in Gynecologic oncology (01.08.2014)
Published in Gynecologic oncology (01.08.2014)
Get full text
Journal Article
Evaluation of the anti-tumor effects of lactate dehydrogenase inhibitor galloflavin in endometrial cancer cells
Han, Xiaoyun, Sheng, Xiugui, Jones, Hannah M, Jackson, Amanda L, Kilgore, Joshua, Stine, Jessica E, Schointuch, Monica N, Zhou, Chunxiao, Bae-Jump, Victoria L
Published in Journal of hematology and oncology (29.01.2015)
Published in Journal of hematology and oncology (29.01.2015)
Get full text
Journal Article
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer1
Schointuch, Monica N., Gilliam, Timothy P., Stine, Jessica E., Han, Xiaoyun, Zhou, Chunxiao, Gehrig, Paola A., Kim, Kenneth, Bae-Jump, Victoria L.
Published in Gynecologic oncology (28.05.2014)
Published in Gynecologic oncology (28.05.2014)
Get full text
Journal Article